Cover image of the article: Effect of Streptokinase immune complex on activation of the complement and interaction with erythrocytes

Image Credit:J Inflamm Dis

Effect of Streptokinase immune complex on activation of the complement and interaction with erythrocytes

Authors

A Afshari, E Holme,*
*Corresponding Author: Email: eholme@mail.com

Journal of Inflammatory Diseases:Vol. 3, issue 3; 5-12
Published online:Dec 31, 1999
Article type:Research Article
How to Cite:Afshari A, Holme E. Effect of Streptokinase immune complex on activation of the complement and interaction with erythrocytes. J Inflamm Dis. 2024;3(3):e154659. doi:

Abstract

Background: One of major disadvantages of streptokinase, a commonly administered thrombolytic agent, is provocation of hypersensitivity. Objective: To determine interactions of the complement and erythrocytes with streptokinase. Methods: The interactions were studied by the measurement of complement activation products C1S: C1:INH and C3b-P, using modified techniques by Auda et al (1990). The kinetics and dose response of streptokinase immune complexes binding to erythrocytes were studied by flowcytometry. Findings: The findings indicated that the binding of ICs to Es depended significantly on the extent of complement activation (P<0.001) and ICs dose of ICs (P<0.001). Conclusion: It can be concluded that the complement system and Es have a central role in preventing the hypersensitivity reactions, in particular type III (Immune complex disease).

Highlights

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

31
Dec
2000
Antibody response to Streptokinase

Antibody response to Streptokinase

A Afshari,
E Holme,
S Hillis

Afshari A, Holme E, Hillis S. Antibody response to Streptokinase. J Inflamm Dis. 2024;4(3):e154721. doi:

30
Sep
2005
Comparison of plasma levels of anticardiolipin and antiphospholipid antibodies in male patients with or without response to streptokinase following acute myocardial infarction

Comparison of plasma levels of anticardiolipin and antiphospholipid antibodies in male patients with or without response to streptokinase following acute myocardial infarction

S Asgary,
G Naderi,
SM Hashemi,
B Sabet,
MR Hadi,
H Esmaeili

Asgary S, Naderi G, Hashemi S, Sabet B, Hadi M, et al. Comparison of plasma levels of anticardiolipin and antiphospholipid antibodies in male patients with or without response to streptokinase following acute myocardial infarction. J Inflamm Dis. 2024;9(2):e155131. doi:

30
Jun
2001
Introducing a new method to detect bound C3d on erythrocytes during complement activation

Introducing a new method to detect bound C3d on erythrocytes during complement activation

A Afshari,
E Holme

Afshari A, Holme E. Introducing a new method to detect bound C3d on erythrocytes during complement activation. J Inflamm Dis. 2024;5(1):e154810. doi:

31
Oct
2012
Biological Activity Analysis of Native and Recombinant Streptokinase Using Clot Lysis and Chromogenic Substrate Assay

Biological Activity Analysis of Native and Recombinant Streptokinase Using Clot Lysis and Chromogenic Substrate Assay

Arash Mahboubi,
Seyyed Kazem Sadjady,
Mohammad Mirzaei Saleh Abadi,
Saeed Azadi,
Roya Solaimanian

Mahboubi A, Sadjady SK, Mirzaei Saleh Abadi M, Azadi S, Solaimanian R. Biological Activity Analysis of Native and Recombinant Streptokinase Using Clot Lysis and Chromogenic Substrate Assay. Iran J Pharm Res. 2012;11(4):e125900. doi: https://doi.org/10.22037/ijpr.2012.1173

25
Jan
2015
Evaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis

Evaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis

Mitra Barati,
Mehdi Shekarabi,
Saeed Chobkar,
Mahshid Talebi-Taher,
Newsha Farhadi

Barati M, Shekarabi M, Chobkar S, Talebi-Taher M, Farhadi N. Evaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis. Arch Clin Infect Dis. 2015;10(1):e26346. doi: https://doi.org/10.5812/archcid.26346

More by these authors

A AfshariPubMedScholar
Share
Cited by
Metrics